V-Square Quantitative Management’s Dr. Reddy's Laboratories RDY Stock Holding History

V-Square Quantitative Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-92,944	Closed	-$1.29M	–	776
2026 Q1	$1.29M	Hold	92,944	–	–	0.14%	139
2025 Q4	$1.3M	Hold	92,944	–	–	0.14%	126
2025 Q3	$1.3M	Buy	92,944 +245	+0.3%	+$3.52K	0.22%	86
2025 Q2	$1.39M	Hold	92,699	–	–	0.19%	108
2025 Q1	$1.22M	Buy	92,699 +2,370	+3%	+$32.7K	0.18%	119
2024 Q4	$1.42M	Buy	90,329 +22,779	+34%	+$342K	0.2%	99
2024 Q3	$1.07M	Hold	67,550	–	–	0.16%	125
2024 Q2	$1.02M	Buy	67,550 +21,300	+46%	+$305K	0.17%	114
2024 Q1	$683K	Hold	46,250	–	–	0.1%	189
2023 Q4	$644K	Buy	+46,250	New	+$618K	0.11%	156

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

V-Square Quantitative Management's RDY Position: Q2 2026 in Review

V-Square Quantitative Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 92,944 shares — an estimated $1.29M sold.

V-Square Quantitative Management first reported a position in RDY in Q4 2023 and held it in 10 quarters. The position peaked at $1.42M in Q4 2024. 58 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

V-Square Quantitative Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
V-Square Quantitative Management sold 92,944 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.29M.
V-Square Quantitative Management first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 10 quarters.
V-Square Quantitative Management's Dr. Reddy's Laboratories position peaked at $1.42M in Q4 2024.
58 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.